000756 新华制药
午间休市 04-07 11:30:00
资讯
新帖
简况
新华制药(000756.SZ)获钠钾镁钙注射用浓溶液药品注册证书
智通财经 · 04-03
新华制药(000756.SZ)获钠钾镁钙注射用浓溶液药品注册证书
市占率第一、营收1亿：光芯片独角兽曦智科技带着“冰与火”赴港递表
华尔街见闻 · 04-02
市占率第一、营收1亿：光芯片独角兽曦智科技带着“冰与火”赴港递表
新华制药最新公告：获得《药品补充申请批准通知书》
证券之星 · 04-01
新华制药最新公告：获得《药品补充申请批准通知书》
新华制药牛黄甲硝唑胶囊补充申请获国家药监局批准
美股速递 · 04-01
新华制药牛黄甲硝唑胶囊补充申请获国家药监局批准
新华制药：董事会审议通过《关于2025年度报告及业绩公告的议案》等多项议案
证券日报 · 03-29
新华制药：董事会审议通过《关于2025年度报告及业绩公告的议案》等多项议案
新华制药(000756)2月28日股东户数7.69万户，较上期减少0.71%
证券之星 · 03-29
新华制药(000756)2月28日股东户数7.69万户，较上期减少0.71%
新华制药(000756.SZ)发布2025年度业绩，归母净利润2.9亿元，同比下降38.32%
智通财经 · 03-29
新华制药(000756.SZ)发布2025年度业绩，归母净利润2.9亿元，同比下降38.32%
股市必读：新华制药（000756）3月23日收盘跌5.23%，主力净流出1938.92万元
证券之星 · 03-24
股市必读：新华制药（000756）3月23日收盘跌5.23%，主力净流出1938.92万元
新华制药(000756.SZ)子公司获布洛芬颗粒药品注册证
智通财经 · 03-23
新华制药(000756.SZ)子公司获布洛芬颗粒药品注册证
新华制药最新公告：获得依折麦布片上市许可持有人变更批准
证券之星 · 03-16
新华制药最新公告：获得依折麦布片上市许可持有人变更批准
新华制药依折麦布片变更上市许可持有人获批准
美股速递 · 03-16
新华制药依折麦布片变更上市许可持有人获批准
新华制药：公司构建创新药+特色原料药+高端制剂+CDMO立体布局
证券日报 · 03-09
新华制药：公司构建创新药+特色原料药+高端制剂+CDMO立体布局
新华制药(000756.SZ)子公司获沙格列汀二甲双胍缓释片药品注册证书
智通财经 · 03-04
新华制药(000756.SZ)子公司获沙格列汀二甲双胍缓释片药品注册证书
新华制药(000756.SZ)获恩他卡朋片药品注册证
智通财经 · 03-04
新华制药(000756.SZ)获恩他卡朋片药品注册证
新华制药沙格列汀与盐酸二甲双胍缓释片获批药品注册证书
美股速递 · 03-04
新华制药沙格列汀与盐酸二甲双胍缓释片获批药品注册证书
新华制药：硫酸氨基葡萄糖胶囊获得药品注册证书
南方财经网 · 02-09
新华制药：硫酸氨基葡萄糖胶囊获得药品注册证书
新华制药硫酸氨基葡萄糖胶囊混悬剂获国家药监局药品注册证书
美股速递 · 02-09
新华制药硫酸氨基葡萄糖胶囊混悬剂获国家药监局药品注册证书
历时14个月未谈拢，新华制药终止挪亚圣诺（太仓）股权收购意向
财中社 · 02-06
历时14个月未谈拢，新华制药终止挪亚圣诺（太仓）股权收购意向
新华制药与Novosana终止股权收购意向协议
美股速递 · 02-06
新华制药与Novosana终止股权收购意向协议
新华制药：新华制药是全球解热镇痛类药物重要生产企业
证券之星 · 02-03
新华制药：新华制药是全球解热镇痛类药物重要生产企业
加载更多
公司概况
公司名称：
山东新华制药股份有限公司
所属行业：
医药制造业
上市日期：
1997-08-06
主营业务：
山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是解热镇痛类等原料药、片剂、针剂、胶囊剂等制剂、医药中间体及其他。
发行价格：
3.45
{"stockData":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":14.8,"timestamp":1775535249000,"preClose":14.72,"halted":0,"volume":3616400,"delay":0,"changeRate":0.0054,"floatShares":499000000,"shares":697000000,"eps":0.1576,"marketStatus":"午间休市","change":0.08,"latestTime":"04-07 11:30:00","open":14.88,"high":14.92,"low":14.52,"amount":53310500,"amplitude":0.0272,"askPrice":14.81,"askSize":29,"bidPrice":14.8,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.1576,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775538000000},"marketStatusCode":3,"adr":0,"adjPreClose":14.72,"symbolType":"stock","openAndCloseTimeList":[[1775525400000,1775532600000],[1775538000000,1775545200000]],"highLimit":16.19,"lowLimit":13.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":696683435,"isCdr":false,"pbRate":1.97,"roa":"--","peRate":93.908629,"roe":"5.66%","epsLYR":0.42,"committee":-0.189066,"marketValue":10311000000,"turnoverRate":0.0072,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-04-08。","hkstockBrief":{"symbol":"00719","market":"HK","secType":"STK","nameCN":"山东新华制药股份","latestPrice":6.4,"timestamp":1775117301002,"preClose":6.4,"halted":0,"volume":456000,"delay":0,"premium":"-62.04"},"floatMarketCap":7384000000},"requestUrl":"/m/hq/s/000756","defaultTab":"news","newsList":[{"id":"2624659134","title":"新华制药(000756.SZ)获钠钾镁钙注射用浓溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2624659134","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624659134?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:41","pubTimestamp":1775209263,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)公告，公司收到国家药品监督管理局核准签发的钠钾镁钙注射用浓溶液《药品注册证书》。本品用于通过中心静脉输注含浓葡萄糖或氨基酸的溶液时的电解质补充，以维持成人患者的电解质动态平衡","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425111.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624579462","title":"市占率第一、营收1亿：光芯片独角兽曦智科技带着“冰与火”赴港递表","url":"https://stock-news.laohu8.com/highlight/detail?id=2624579462","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624579462?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:06","pubTimestamp":1775117205,"startTime":"0","endTime":"0","summary":"相信光的力量？","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3769090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000756","BK4588","LITE","BIDU","BK4535","COHR","00719","09888","TCEHY","NVDA","BK4585","00700"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2624151081","title":"新华制药最新公告：获得《药品补充申请批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2624151081","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624151081?lang=zh_cn&edition=full","pubTime":"2026-04-01 23:50","pubTimestamp":1775058649,"startTime":"0","endTime":"0","summary":"新华制药(000756.SZ)公告称，公司近日收到国家药品监督管理局核准签发的人工牛黄甲硝唑胶囊《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100043106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112736876","title":"新华制药牛黄甲硝唑胶囊补充申请获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1112736876","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112736876?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:38","pubTimestamp":1775032692,"startTime":"0","endTime":"0","summary":"山东新华制药股份有限公司（股票代码：000756）近日宣布，其牛黄甲硝唑胶囊的补充药品注册申请已获得国家药品监督管理局（NMPA）正式批准。\n此次获批标志着该产品在临床应用范围或生产工艺优化等方面取得新的进展，有望为患者提供更安全、有效的治疗选择，同时也将进一步提升新华制药在消化系统及抗感染药物市场的竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000756","BK0164","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623635936","title":"新华制药：董事会审议通过《关于2025年度报告及业绩公告的议案》等多项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2623635936","media":"证券日报","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623635936?lang=zh_cn&edition=full","pubTime":"2026-03-29 20:15","pubTimestamp":1774786500,"startTime":"0","endTime":"0","summary":"证券日报网讯3月29日，新华制药发布公告称，公司第十一届董事会第十次会议审议通过《关于2025年度报告及业绩公告的议案》《关于2025年度利润分配的议案》《关于续聘会计师事务所的议案》等多项议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603293688038165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623358004","title":"新华制药(000756)2月28日股东户数7.69万户，较上期减少0.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623358004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623358004?lang=zh_cn&edition=full","pubTime":"2026-03-29 17:02","pubTimestamp":1774774943,"startTime":"0","endTime":"0","summary":"证券之星消息，近日新华制药披露，截至2026年2月28日公司股东户数为7.69万户，较12月31日减少550.0户，减幅为0.71%。在化学制药行业个股中，新华制药股东户数高于行业平均水平，截至2月28日，化学制药行业平均股东户数为3.44万户。从股价来看，2025年12月31日至2026年2月28日，新华制药区间涨幅为3.05%，在此期间股东户数减少550.0户，减幅为0.71%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900007905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623935817","title":"新华制药(000756.SZ)发布2025年度业绩，归母净利润2.9亿元，同比下降38.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623935817","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623935817?lang=zh_cn&edition=full","pubTime":"2026-03-29 16:36","pubTimestamp":1774773386,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)披露2025年年度报告，报告期公司实现营收87.55亿元，同比增长3.41%;归母净利润2.9亿元，同比下降38.32%;扣非净利润2.68亿元，同比下降40.10%;基本每股收益0.42元。公司拟向全体股东派发2025年末期股息每股人民币0.15元(含税)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"新华制药(000756.SZ)发布2025年度业绩，归母净利润2.9亿元，同比下降38.32%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621085869","title":"股市必读：新华制药（000756）3月23日收盘跌5.23%，主力净流出1938.92万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621085869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621085869?lang=zh_cn&edition=full","pubTime":"2026-03-24 01:43","pubTimestamp":1774287791,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，新华制药报收于13.96元，下跌5.23%，换手率1.8%，成交量9.0万手，成交额1.27亿元。当日关注点来自交易信息汇总：新华制药股价连续5日下跌，3月23日收盘跌5.23%，主力资金当日净流出1938.92万元。前10个交易日主力资金累计净流出9175.79万元，股价累计下跌8.91%；融资余额累计减少1165.87万元，融券余量累计减少1.11万股。本次获批进一步丰富公司布洛芬产品剂型，但药品销售受政策和市场因素影响存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400001661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621877984","title":"新华制药(000756.SZ)子公司获布洛芬颗粒药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2621877984","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621877984?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:58","pubTimestamp":1774256281,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)公告，公司全资子公司山东淄博新达制药有限公司(简称“新达制药”)收到国家药品监督管理局核准签发的布洛芬颗粒《药品注册证书》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1417374.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619518024","title":"新华制药最新公告：获得依折麦布片上市许可持有人变更批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2619518024","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619518024?lang=zh_cn&edition=full","pubTime":"2026-03-16 18:00","pubTimestamp":1773655203,"startTime":"0","endTime":"0","summary":"新华制药(000756.SZ)公告称，公司收到国家药品监督管理局核准签发的依折麦布片《药品补充申请批准通知书》，批准本品上市许可持有人转让补充申请。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600026281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164703743","title":"新华制药依折麦布片变更上市许可持有人获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1164703743","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164703743?lang=zh_cn&edition=full","pubTime":"2026-03-16 17:37","pubTimestamp":1773653830,"startTime":"0","endTime":"0","summary":"山东新华制药股份有限公司近日宣布，其生产的依折麦布片变更上市许可持有人的申请已获得相关监管部门的批准。此次变更将有助于公司优化产品管理结构，提升市场运营效率。依折麦布片作为一种重要的降血脂药物，其上市许可持有人的变更不会影响产品的质量和市场供应，公司将继续确保该药品的安全性和有效性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618259096","title":"新华制药：公司构建创新药+特色原料药+高端制剂+CDMO立体布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2618259096","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618259096?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:10","pubTimestamp":1773058240,"startTime":"0","endTime":"0","summary":"证券日报网讯3月9日，新华制药在互动平台回答投资者提问时表示，公司以大研发+全产业链+国际化为核心，构建创新药+特色原料药+高端制剂+CDMO的立体布局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603093666266727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","BK0164","BK0239","06978","000756","CDMO","159992","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616389205","title":"新华制药(000756.SZ)子公司获沙格列汀二甲双胍缓释片药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2616389205","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616389205?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:56","pubTimestamp":1772614570,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)公告，公司全资子公司山东淄博新达制药有限公司(简称“新达制药”)收到国家药品监督管理局核准签发的沙格列汀二甲双胍缓释片(Ⅰ)、(Ⅲ)《药品注册证书》。本品配合饮食和运动治疗，适合使用沙格列汀和二甲双胍治疗的2型糖尿病成人患者，以改善此类患者的血糖控制。本品不用于1型糖尿病或糖尿病酮症酸中毒的患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409957.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000756","BK0239","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616953896","title":"新华制药(000756.SZ)获恩他卡朋片药品注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2616953896","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616953896?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:49","pubTimestamp":1772614182,"startTime":"0","endTime":"0","summary":"智通财经APP讯，新华制药(000756.SZ)公告，公告收到国家药品监督管理局核准签发的恩他卡朋片《药品注册证书》。本品可作为标准药物左旋多巴/苄丝肼或左旋多巴/卡比多巴的辅助用药，用于治疗以上药物不能控制的帕金森病及剂末现象(症状波动)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409951.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"新华制药(000756.SZ)获恩他卡朋片药品注册证","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190496711","title":"新华制药沙格列汀与盐酸二甲双胍缓释片获批药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1190496711","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190496711?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:31","pubTimestamp":1772613076,"startTime":"0","endTime":"0","summary":"新华制药（股票代码：000756）宣布，其研发的沙格列汀与盐酸二甲双胍缓释片正式获得国家药品监督管理局颁发的药品注册证书。该药物主要用于2型糖尿病患者的血糖控制，结合了DPP-4抑制剂与双胍类药物的协同降糖机制。\n此次获批标志着公司在内分泌代谢疾病治疗领域取得重要突破。缓释剂型可减少患者服药频率，提升用药依从性，为糖尿病治疗提供更优选择。随着国内糖尿病患病率持续上升，该产品有望进一步丰富新华制药的代谢类药品管线，增强市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610663896","title":"新华制药：硫酸氨基葡萄糖胶囊获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2610663896","media":"南方财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610663896?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:54","pubTimestamp":1770627297,"startTime":"0","endTime":"0","summary":"南财智讯2月9日电，新华制药公告，公司收到国家药品监督管理局签发的硫酸氨基葡萄糖胶囊《药品注册证书》。该产品用于治疗原发性及继发性骨关节炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602093645467176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162349391","title":"新华制药硫酸氨基葡萄糖胶囊混悬剂获国家药监局药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=1162349391","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162349391?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:34","pubTimestamp":1770626066,"startTime":"0","endTime":"0","summary":"新华制药（000756）宣布，其研发的硫酸氨基葡萄糖胶囊混悬剂已正式获得国家药品监督管理局（NMPA）颁发的药品注册证书。该药品注册证书的取得，标志着公司该产品已获准在中国市场生产销售，有望进一步丰富公司产品线，并对未来业绩产生积极影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609568560","title":"历时14个月未谈拢，新华制药终止挪亚圣诺（太仓）股权收购意向","url":"https://stock-news.laohu8.com/highlight/detail?id=2609568560","media":"财中社","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609568560?lang=zh_cn&edition=full","pubTime":"2026-02-06 19:35","pubTimestamp":1770377715,"startTime":"0","endTime":"0","summary":"2月6日，新华制药（000756/00719）发布公告，2024年10月，公司披露拟受让NovoSana（Europe）B.V.持有的挪亚圣诺（太仓）生物科技有限公司不超过75%股权。收购完成后，公司将成为挪亚圣诺的控股股东，目标公司将纳入本公司合并报表范围。基于双方没有达成一致意见，根据协议终止条款，意向协议终止，其所涉及的所有条款均终止履行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602063644262750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK0164","000756"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133227148","title":"新华制药与Novosana终止股权收购意向协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1133227148","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133227148?lang=zh_cn&edition=full","pubTime":"2026-02-06 17:55","pubTimestamp":1770371724,"startTime":"0","endTime":"0","summary":"新华制药宣布，公司与Novosana（欧洲）B.V.已共同决定终止此前签署的股权收购意向协议。该协议涉及双方在医药领域的潜在合作，但经协商一致，决定不再推进此项交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","000756","BK0164"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608381416","title":"新华制药：新华制药是全球解热镇痛类药物重要生产企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2608381416","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608381416?lang=zh_cn&edition=full","pubTime":"2026-02-03 09:01","pubTimestamp":1770080467,"startTime":"0","endTime":"0","summary":"证券之星消息，新华制药02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：据报，截止2月2日，全球流感蔓延爆发，美洲：美国本季累计病例超 2000 万，住院≥27 万，死亡≥1.1 万，近期活动回升，儿童住院率与死亡数显著走高；中美洲、加勒比地区阳性率超 30%。新华制药是全球解热镇痛类药物重要生产企业，目前出口情况并无显著变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300007618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","000756","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775535261653,"stockEarnings":[{"period":"1week","weight":-0.0147},{"period":"1month","weight":-0.0284},{"period":"3month","weight":-0.0448},{"period":"6month","weight":-0.0515},{"period":"1year","weight":-0.0232},{"period":"ytd","weight":-0.0448}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":-0.0496},{"period":"3month","weight":-0.0224},{"period":"6month","weight":-0.0007},{"period":"1year","weight":0.161},{"period":"ytd","weight":-0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东新华制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"76941人(较上一季度减少0.71%)","perCapita":"6484股","listingDate":"1997-08-06","address":"山东省淄博市张店区高新技术产业开发区化工区","registeredCapital":"69668万元","survey":" 山东新华制药股份有限公司的主营业务是开发、制造和销售化学原料药、制剂及化工产品。公司的主要产品是解热镇痛类等原料药、片剂、针剂、胶囊剂等制剂、医药中间体及其他。","listedPrice":3.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新华制药,000756,新华制药股票,新华制药股票老虎,新华制药股票老虎国际,新华制药行情,新华制药股票行情,新华制药股价,新华制药股市,新华制药股票价格,新华制药股票交易,新华制药股票购买,新华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}